BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 15655365)

  • 1. Revisiting the "Cdk-centric" view of the mammalian cell cycle.
    Malumbres M
    Cell Cycle; 2005 Feb; 4(2):206-10. PubMed ID: 15655365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclins and CDKS in development and cancer: lessons from genetically modified mice.
    Santamaria D; Ortega S
    Front Biosci; 2006 Jan; 11():1164-88. PubMed ID: 16146805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
    Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
    Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of p27-CDK complexes during the human mitotic cell cycle.
    Soos TJ; Kiyokawa H; Yan JS; Rubin MS; Giordano A; DeBlasio A; Bottega S; Wong B; Mendelsohn J; Koff A
    Cell Growth Differ; 1996 Feb; 7(2):135-46. PubMed ID: 8822197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Established and novel Cdk/cyclin complexes regulating the cell cycle and development.
    Gopinathan L; Ratnacaram CK; Kaldis P
    Results Probl Cell Differ; 2011; 53():365-89. PubMed ID: 21630153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin-dependent kinase regulation during G1 phase and cell cycle regulation by TGF-beta.
    Ravitz MJ; Wenner CE
    Adv Cancer Res; 1997; 71():165-207. PubMed ID: 9111866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G1 control in mammalian cells.
    Reed SI; Bailly E; Dulic V; Hengst L; Resnitzky D; Slingerland J
    J Cell Sci Suppl; 1994; 18():69-73. PubMed ID: 7883795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current concepts in neuro-oncology: the cell cycle--a review.
    Dirks PB; Rutka JT
    Neurosurgery; 1997 May; 40(5):1000-13; discussion 1013-5. PubMed ID: 9149259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs.
    Roskoski R
    Pharmacol Res; 2019 Jan; 139():471-488. PubMed ID: 30508677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into cyclins, CDKs, and cell cycle control.
    Sánchez I; Dynlacht BD
    Semin Cell Dev Biol; 2005 Jun; 16(3):311-21. PubMed ID: 15840440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functions of cyclins and CDKs in mammalian gametogenesis†.
    Chotiner JY; Wolgemuth DJ; Wang PJ
    Biol Reprod; 2019 Sep; 101(3):591-601. PubMed ID: 31078132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle, CDKs and cancer: a changing paradigm.
    Malumbres M; Barbacid M
    Nat Rev Cancer; 2009 Mar; 9(3):153-66. PubMed ID: 19238148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs).
    Graña X; Reddy EP
    Oncogene; 1995 Jul; 11(2):211-9. PubMed ID: 7624138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cell cycle and parathyroid tumor].
    Matsushime H
    Nihon Rinsho; 1995 Apr; 53(4):844-9. PubMed ID: 7752470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-alpha-induced G1 phase arrest through up-regulated expression of CDK inhibitors, p19Ink4D and p21Cip1 in mouse macrophages.
    Matsuoka M; Tani K; Asano S
    Oncogene; 1998 Apr; 16(16):2075-86. PubMed ID: 9572488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cyclin-dependent kinase inhibitors in mammal cells].
    Jiang H; Wang YC
    Sheng Li Ke Xue Jin Zhan; 1996 Apr; 27(2):107-12. PubMed ID: 9592231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of G1 progression by D-type cyclins: key event for cell proliferation.
    Kato JY
    Leukemia; 1997 Apr; 11 Suppl 3():347-51. PubMed ID: 9209386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip).
    Chen WJ; Chang CY; Lin JK
    Biochem Pharmacol; 2003 Jun; 65(11):1777-85. PubMed ID: 12781329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth factor-regulated G1 cyclins.
    Sherr CJ
    Stem Cells; 1994; 12 Suppl 1():47-55; discussion 55-7. PubMed ID: 7696969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of CDK/cyclin complexes during the cell cycle.
    Arellano M; Moreno S
    Int J Biochem Cell Biol; 1997 Apr; 29(4):559-73. PubMed ID: 9363633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.